HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cruelty Free International’s China Entry Pilot Enrolls Edgewell’s Bulldog, Neal’s Yard Remedies

This article was originally published in The Rose Sheet

Executive Summary

Australian company Subtle Energies and UK-based 7th Heaven round out the group of cruelty-free cosmetics brands selected for participation in CFI’s pilot program, which organizers say is not only greasing the skids for aspiring China market entrants that want to avoid animal testing, but also spurring discussion about alternative testing methods.

You may also be interested in...



US Humane Cosmetics Act Backed By Industry And NGOs Alike; Here’s Why

The proposed bill in the US Senate could be seen as slightly friendlier to the cosmetics industry when it comes to continued use of animal testing data in limited, exempted contexts, compared with similar state laws enacted of late. But the federal bill includes stiffer penalties, addresses “cruelty free” labeling, and seeks to spur FDA acceptance of alternative test methods, a key objective for stakeholders overall.

Edgewell’s Q4 Reflects Ongoing Men’s Shave Challenges, REACH Sun-Care Reformulation

Despite positive impacts from its Hydro 5 Sense and Intuition f.a.b. razor launches, Edgewell’s global Wet Shave business declined in the fourth quarter and full fiscal 2018. The firm remains focused on slashing costs, an effort that wasn’t helped by a Q4 charge related to REACH ingredient substitution.

FDA Guarded On California Animal-Testing Ban’s Implications For Federal Cosmetics Compliance

The agency isn’t saying much about California’s new law, but it has indicated previously that alternative methods may not hold up under federal regulatory scrutiny should safety issues arise. FDA and other regulators also have noted that manufacturers’ liability when relying on experimental safety assessment techniques has yet to be tested in the courts.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS122551

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel